Kurma plans to raise a total of 250 million euros ($276 million) for the fund, dubbed Biofund IV, which would make it the ...

In addition to its two polyomavirus lead compounds, Orthogon has the first ever Glycyl tRNA synthetase–targeting small molecule in preclinical development to treat Enterobacteriaceae and ...

Vera is also developing MAU868, a monoclonal antibody designed to neutralize infection with BK virus (BKV), a polyomavirus ...

and Merkel cell polyomavirus, or MCPyV, which is linked to 80 percent of cases of a rare but aggressive skin cancer called Merkel cell carcinoma, or MCC. Dr. Galloway’s HPV work helped pave the way ...

The R&D Day event was held in advance of the anticipated 96-week data from the Phase 2b ORIGIN study of atacicept in IgAN, ...

Unlike chimeric antigen receptor (CAR) T-cell therapies, which can identify surface antigens, TCR-T cell therapies like ...

Collaborating with UW’s Dr. Paul Nghiem, Dr. Chapuis is testing Merkel-Cell polyomavirus-specific T cells for patients with metastatic Merkel Cell Carcinoma., an aggressive skin cancer. The most ...